WELL Health Technologies Corp. (TSX:WELL)
Canada flag Canada · Delayed Price · Currency is CAD
3.840
+0.050 (1.32%)
Nov 13, 2026, 4:00 PM EST

WELL Health Technologies Financials Overview

Millions CAD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,5611,400919.69776.05569.14302.32
Revenue Growth
24.85%52.24%18.51%36.36%88.25%501.76%
Gross Profit
696.29618.84363.01372.27303.29153.7
Operating Income
79.3193.59-29.8634.5233.081.46
Net Income
-128.76-7.3632.610.081.37-44.18
Earnings Per Share
-0.50-0.030.130.000.01-0.23
EPS Growth
--37471.96%-94.42%--

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Saas and Technology Services
98.5886.5772.8773.1860.96-
Canadian Patient Services - Primary WMC
367.82279.24191.89119.2177.83-
WELL Health USA Patient Services - Specialized CRH Medical
307.09293.61234.72249.42202.14132.5
Healwell
133.97113.56----
WELL Health USA Patient Services - Primary WISP
114.63115.03100.9777.8858.18-
WELL Health USA Patient Services - Specialized-Provider Staffing
207.58214.21123.1355.42--
Canadian Patient Services - Specialized WDC
199.41166.52127.56111.32104.2442.46
Corporate/Eliminations
42.6520.6615.916.9414.3915.24
WELL Health USA Patient Services - Primary Circle Medical
130.15145.176.396.6269.4-
Inter-Segment
-41.01-34.32-23.65-23.93-18.01-17.24
Total
1,5611,400919.69776.05569.14302.32

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
216.66133.76131.6743.4248.9161.92
Total Debt
911.22714.08473.14426.28358.42401.94
Net Cash (Debt)
-694.56-580.32-341.47-382.86-309.51-340.02
Net Cash Growth
------
Net Cash Per Share
-2.72-2.30-1.34-1.62-1.40-1.78

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
114.09121.899.5266.4476.5522.27
Capital Expenditures
-41.21-40.15-26.52-25.38-6.62-52.48
Free Cash Flow
72.8781.74-1741.0569.93-30.21
Free Cash Flow Growth
4.73%---41.30%--

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
44.61%44.20%39.47%47.97%53.29%50.84%
Operating Margin
5.08%6.68%-3.25%4.45%5.81%0.48%
Pretax Margin
-7.70%0.38%0.98%2.51%3.08%-8.43%
Profit Margin
-8.25%-0.53%3.55%0.01%0.24%-14.61%
FCF Margin
4.67%5.84%-1.85%5.29%12.29%-9.99%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--52.4011335.33477.46-
Forward PE
9.6841.96226.40196.02196.02196.02
P/FCF Ratio
13.5212.40-22.649.35-
PS Ratio
0.630.721.861.201.153.38